Your browser doesn't support javascript.
loading
B cell receptor ligation induces IgE plasma cell elimination.
Wade-Vallance, Adam K; Yang, Zhiyong; Libang, Jeremy B; Robinson, Marcus J; Tarlinton, David M; Allen, Christopher D C.
Afiliación
  • Wade-Vallance AK; Biomedical Sciences Graduate Program, University of California, San Francisco , San Francisco, CA, USA.
  • Yang Z; Cardiovascular Research Institute, University of California, San Francisco , San Francisco, CA, USA.
  • Libang JB; Sandler Asthma Basic Research Center, University of California, San Francisco , San Francisco, CA, USA.
  • Robinson MJ; Cardiovascular Research Institute, University of California, San Francisco , San Francisco, CA, USA.
  • Tarlinton DM; Sandler Asthma Basic Research Center, University of California, San Francisco , San Francisco, CA, USA.
  • Allen CDC; Cardiovascular Research Institute, University of California, San Francisco , San Francisco, CA, USA.
J Exp Med ; 220(4)2023 04 03.
Article en En | MEDLINE | ID: mdl-36880536
ABSTRACT
The proper regulation of IgE production safeguards against allergic disease, highlighting the importance of mechanisms that restrict IgE plasma cell (PC) survival. IgE PCs have unusually high surface B cell receptor (BCR) expression, yet the functional consequences of ligating this receptor are unknown. Here, we found that BCR ligation induced BCR signaling in IgE PCs followed by their elimination. In cell culture, exposure of IgE PCs to cognate antigen or anti-BCR antibodies induced apoptosis. IgE PC depletion correlated with the affinity, avidity, amount, and duration of antigen exposure and required the BCR signalosome components Syk, BLNK, and PLCγ2. In mice with a PC-specific impairment of BCR signaling, the abundance of IgE PCs was selectively increased. Conversely, BCR ligation by injection of cognate antigen or anti-IgE depleted IgE PCs. These findings establish a mechanism for the elimination of IgE PCs through BCR ligation. This has important implications for allergen tolerance and immunotherapy as well as anti-IgE monoclonal antibody treatments.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Hipersensibilidad Límite: Animals Idioma: En Revista: J Exp Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Plasmáticas / Hipersensibilidad Límite: Animals Idioma: En Revista: J Exp Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos